444 related articles for article (PubMed ID: 31633228)
1. Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study.
Pacheco-Paez T; Montastruc F; Rousseau V; Chebane L; Lapeyre-Mestre M; Renoux C; Montastruc JL
Mov Disord; 2020 Jan; 35(1):176-180. PubMed ID: 31633228
[TBL] [Abstract][Full Text] [Related]
2. Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
Evoy KE; Peckham AM; Covvey JR; Tidgewell KJ
J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S89-S99. PubMed ID: 34396549
[TBL] [Abstract][Full Text] [Related]
3. Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case-crossover study.
Ri K; Fukasawa T; Yoshida S; Takeuchi M; Kawakami K
Pharmacotherapy; 2023 Feb; 43(2):136-144. PubMed ID: 36633384
[TBL] [Abstract][Full Text] [Related]
4. Gabapentinoids Suppress Lipopolysaccharide-Induced Interleukin-6 Production in Primary Cell Cultures of the Rat Spinal Dorsal Horn.
Nürnberger F; Rummel C; Ott D; Gerstberger R; Schmidt MJ; Roth J; Leisengang S
Neuroimmunomodulation; 2023; 30(1):1-14. PubMed ID: 35843206
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
[TBL] [Abstract][Full Text] [Related]
7. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
Chiappini S; Schifano F
CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
[TBL] [Abstract][Full Text] [Related]
8. Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
Vickers-Smith R; Sun J; Charnigo RJ; Lofwall MR; Walsh SL; Havens JR
Drug Alcohol Depend; 2020 Jan; 206():107709. PubMed ID: 31732295
[TBL] [Abstract][Full Text] [Related]
9. Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015.
Daly C; Griffin E; Ashcroft DM; Webb RT; Perry IJ; Arensman E
Clin Drug Investig; 2018 Apr; 38(4):373-380. PubMed ID: 29264838
[TBL] [Abstract][Full Text] [Related]
10. [On the risk of dependence on gabapentinoids].
Bonnet U; Scherbaum N
Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
[TBL] [Abstract][Full Text] [Related]
11. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
[No Abstract] [Full Text] [Related]
12. How addictive are gabapentin and pregabalin? A systematic review.
Bonnet U; Scherbaum N
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1185-1215. PubMed ID: 28988943
[TBL] [Abstract][Full Text] [Related]
13. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
Kim SC; Landon JE; Lee YC
Arthritis Res Ther; 2015 Jan; 17(1):18. PubMed ID: 25627453
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin and gabapentin in non-opioid poisoning deaths.
Kriikku P; Ojanperä I
Forensic Sci Int; 2021 Jul; 324():110830. PubMed ID: 34000615
[TBL] [Abstract][Full Text] [Related]
15. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
[TBL] [Abstract][Full Text] [Related]
16. Abuse and Misuse of Pregabalin and Gabapentin.
Evoy KE; Morrison MD; Saklad SR
Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
[TBL] [Abstract][Full Text] [Related]
17. A Case of Pregabalin-Induced Parkinsonism.
Ari BC; Domac FM; Kenangil GO
Neurol India; 2020; 68(6):1469-1471. PubMed ID: 33342895
[TBL] [Abstract][Full Text] [Related]
18. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
[TBL] [Abstract][Full Text] [Related]
19. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
[TBL] [Abstract][Full Text] [Related]
20. Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study.
Muanda FT; Weir MA; Ahmadi F; Sontrop JM; Cowan A; Fleet JL; Blake PG; Garg AX
Am J Kidney Dis; 2022 Jul; 80(1):98-107.e1. PubMed ID: 34979160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
